immunotherapy

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

immunotherapy
May 31, 2025, 18:39 | Blog
Pembrolizumab Helps Head and Neck Cancer Patients Live Years Longer Cancer-Free - The Institute of Cancer Research
The Institute of Cancer Research shared a post on LinkedIn: "BREAKING: Researchers at the ICR…
May 31, 2025, 10:22 | Oncolibrary
CheckMate 8HW Trial at ASCO 2025: Nivolumab Plus Ipilimumab Sets New Standard for MSI-H/dMMR Metastatic Colorectal Cancer
The phase 3 CheckMate 8HW study, presented at the ASCO 2025 annual meeting, delivers compelling…
May 31, 2025, 10:13 | Blog
Patrick Hwu: The Importance of Combination Immunotherapy Strategies in Overcoming Resistance at ASCO25
Patrick Hwu, President and CEO of the Moffitt Cancer Center, posted on X: "Also enjoyed…
May 29, 2025, 17:41 | Blog
Amol Akhade: Can Perioperative Immunotherapy Change Outcomes in Resectable Gastric/GEJ Cancer?
Amol Akhade, Consultant Medical Oncologist at the Suyog Cancer Clinics, shared a post on LinkedIn:…
May 29, 2025, 17:28 | Science
Praveen Kumar Marimuthu: RWD Shows NACT Plus Immunotherapy Nearly Doubles pCR in MIBC
Praveen Kumar Marimuthu, Assistant Professor of Medical Oncology at Christian Medical College and Hospital, shared…
May 29, 2025, 12:53 | Blog
Aleix Prat: Representing Both the Clínic Barcelona Comprehensive Cancer Center and Reveal Genomics at ASCO25
Aleix Prat, Director of the Cancer Institute at the Hospital Clinic of Barcelona, shared a post…
May 29, 2025, 12:19 | Blog
Agenus Addresses Rising Colorectal Cancer Rates in Younger Adults
Agenus shared a post on LinkedIn: "Colorectal cancer is being diagnosed in younger people—those under 50—at…
May 28, 2025, 13:21 | Insight
May is Cancer Research Month: Advancing Science, Saving Lives
Every May, we celebrate National Cancer Research Month, recognizing the lifesaving impact of cancer research…
May 28, 2025, 11:51 | Blog
Fiona Thistlethwaite - Pushing the Boundaries of Cancer Research and Personalised Medicine - MCRC
Manchester Cancer Research Centre shared a post on LinkedIn: "Alumni Spotlight: Professor Fiona Thistlethwaite. After finishing…
May 27, 2025, 12:16 | Blog
The Most Recent Articles from ESMOBreast25 on latest Developments in Breast Cancer
ESMO - European Society for Medical Oncology shared a post on LinkedIn: "Interested in the latest…
May 26, 2025, 08:09 | Blog
Luciano Costa: JNJ-5322 is Likely The Greatest Innovation We Have Seen in a Few Years
Luciano J Costa, Professor at University of Alabama at Birmingham, shared a post on X:…
May 26, 2025, 06:10 | Blog
Jason Mouabbi: Excitement is Building for ASCO25
Jason Mouabbi, Assistant professor of breast medical oncology at The University of Texas MD Anderson…
May 25, 2025, 14:50 | Insight
Kunal Jobanputra Shares Key Clinical Studies from ASCO 2025
Kunal Jobanputra, Community Medical Oncologist at Tata Memorial Hospital, shared some studies from ASCO 2025:…
May 25, 2025, 10:39 | Science
Marko Skelin: New Meta-Analysis on Immunotherapy’s Role in Treating Mesothelioma
Marko Skelin, Assistant Professor at University of Rijeka, shared an article on LinkedIn: "New Insights…
May 25, 2025, 06:24 | Blog
Bernard Fox: TIMO2025 - Great line-up of Immunotherapy Experts
Bernard Fox, Co-Founder, President and CEO of UbiVac, posted on X: "TIMO2025 Great line-up of…
May 24, 2025, 11:18 | Opinion
New Paper Alert: APOLLO Trial. Anlotinib Plus Penpulimab vs Sorafenib in First-Line Treatment of Unresectable Hepatocellular Carcinoma:
The APOLLO trial marks a significant advancement in the treatment landscape of unresectable hepatocellular carcinoma…
May 24, 2025, 06:16 | Oncolibrary
KEYNOTE-991 Trial Results: Pembrolizumab Plus Enzalutamide and ADT in mHSPC
KEYNOTE-991 is a pivotal phase III trial that explored whether adding pembrolizumab to enzalutamide and…
May 23, 2025, 12:45 | Cancer Center Near Me
Penn Medicine: Cancer Center Near Me
Founded in 1765, Penn Medicine is the nation’s first medical school and a leading academic…
May 23, 2025, 11:16 | Blog
John Gordon: SERT as a Novel Target in Cancer Immunotherapy via SSRIs
John Gordon, Co-Founder, Director and VP of Scientific Affairs at Celentyx, shared a post on LinkedIn:…
May 22, 2025, 14:18 | Cancer Types
Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer
This article provides an up-to-date, in-depth overview of cholangiocarcinoma (bile duct cancer) as of 2025.…
May 21, 2025, 11:58 | Science
Vivek Subbiah: Designing Clinical Trials for Patients With Rare Cancers
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared an…
May 20, 2025, 13:05 | Cancer Types
Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management
Pheochromocytoma is a rare adrenal tumor known for causing sudden spikes in blood pressure and…
May 20, 2025, 07:03 | Insight
David Gandara: Clinical and Biological Implications of Plasma Proteomics in NSCLC Presented at AACR 2025
David Gandara, Co-Director of the Center for Experimental Therapeutics at the UC Davis Comprehensive Cancer Center,…
May 19, 2025, 18:28 | Blog
Cancer treatment has evolved dramatically - FDA Oncology
FDA Oncology shared on X: "Cancer treatment has evolved dramatically! Then: Surgery and radiation were…
May 19, 2025, 13:41 | Oncolibrary,Opinion
New Paper Alert: NO LIMIT Trial. First-Line Nivolumab Plus Low-Dose Ipilimumab in MSI-High Advanced Gastric and GEJ Cancer
The NO LIMIT (WJOG13320G) Phase II trial investigates a novel, chemotherapy-free first-line approach using nivolumab…
May 19, 2025, 13:02 | Insight
Amol Akhade: New Development Therapeutic Data to Watch at ASCO 2025
Amol Akhade, Consultant Medical Oncologist at the Suyog Cancer Clinics, shared a post on LinkedIn:…
May 18, 2025, 11:49 | Blog
How Cancer Treatment Has Transformed with Modern Therapies - FDA Oncology
FDA Oncology shared a post on X: "Cancer treatment has evolved dramatically! Then, Surgery and…
May 18, 2025, 11:43 | Blog
Goutham Sunny: Immunotherapy in MSI-H Gastric Cancer - NO LIMIT trial
Goutham Sunny, Resident Doctor at The Gujarat Cancer and Research Institute, posted on X: "Immunotherapy…
May 17, 2025, 15:36 | Blog
Rasha Aboelhassan: Should we Give Chemotherapy with Immunotherapy as a Neoadjuvant Setting in stage I TNBC?
Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared a post on LinkedIn: "Elisabetta…
May 17, 2025, 02:12 | Blog
Inspiring Journey of the 2024 Yvonne Awardees — A Year of Impact and Leadership
In 2024, the Yvonne Awards honored a remarkable group of oncology leaders across diverse categories—from…
May 16, 2025, 13:21 | Oncolibrary
FDA Approves Retifanlimab-dlwr with Chemotherapy and as Monotherapy for Advanced Squamous Cell Carcinoma of the Anal Canal
On May 15, 2025, the U.S. Food and Drug Administration (FDA) approved retifanlimab-dlwr (Zynyz, Incyte…
May 16, 2025, 08:31 | Blog
Wafik S. El-Deiry: Karl Kelsey Presents on Immunotherapy Biomarkers in Head and Neck Cancer at Brown University
Wafik S. El-Deiry, Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and…
May 15, 2025, 15:08 | Science
Praveen Kumar Marimuthu: Preliminary Results with the Combo of Chemo, OMT and Low-Dose Nivo in Unresectable Oral Cancers
Praveen Kumar Marimuthu, DM Resident in Medical Oncology at the Christian Medical College and Hospital, reshared…
May 15, 2025, 10:23 | Blog
Highlights from ROME LUNG 25: A Global Gathering of Lung Cancer Experts
The 4th International Summit on Lung Cancer—ROME LUNG 25—was held on May 10–11, 2025, at…
May 13, 2025, 10:26 | Blog
Goutham Sunny: Economic Crisis Affected Access to Immunotherapy in Metastatic NSCLC
Goutham Sunny, Resident Doctor at The Gujarat Cancer and Research Institute, shared a post on X:…
May 11, 2025, 14:35 | Blog
Christian Rolfo: ADC in Combination with Immunotherapy in NSCLC by Stephen V Liu
Christian Rolfo, Division Director of Medical Oncology and Associate Director for Early Phase Clinical Trials at…
May 11, 2025, 13:58 | Blog
Domenico Galetta: Interesting and Intense Discussion on the Role of Neoadjuvant vs Perioperative Chemo-Immunotherapy at RomeLung25
Domenico Galetta, Medical oncologist at IRCCS Giovanni Paolo II, shared a post on X: "Very…
May 11, 2025, 13:57 | Science
Giannis Mountzios: Shedding Light on Factors Influencing Treatment Sequence in BRAF Mutant NSCLC
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant…
May 11, 2025, 07:48 | Cancer Types
Meningioma: Types, Symptoms, Diagnosis, Treatment, Malignancy Risk, and 2025 Breakthroughs
This article offers a comprehensive overview of meningioma, the most common primary brain tumor in…
May 11, 2025, 06:52 | Blog
PSOGI Explores Evolving Approaches to MSI-H Colorectal Peritoneal Metastases in Case of the Month
Peritoneal Surface Oncology Group International (PSOGI) posted on X: "CASE OF THE MONTH 40 Summarized…
May 9, 2025, 12:42 | Drugs
Penpulimab: What patients need to know?
Penpulimab, also known by its generic name penpulimab-kcqx, is a newly FDA-approved immunotherapy for certain…
May 9, 2025, 11:44 | Blog
Susanna Fletcher Greer: A Surprising Immune Cell that could reshape how we Monitor and Mobilize Anti-Tumor Immunity
Susanna Fletcher Greer, Chief Scientific Officer at the V Foundation, shared a post on LinkedIn: "Hidden…
May 9, 2025, 09:15 | Drugs
Penpulimab: Uses in Cancer, Side Effects, Dosage, Expectations, and More
​Penpulimab is a novel humanized monoclonal antibody that targets PD-1 (programmed death-1), a key immune…
May 8, 2025, 18:00 | Career
E. John Wherry elected to National Academy of Sciences for cancer immunotherapy research
Parker Institute for Cancer Immunotherapy shared a post on X: "Congrats to E. John Wherry,…
May 8, 2025, 11:47 | Blog
The Official Launch of the International Summit in Immuno-Oncology - Santé Arménie Medical Academy
Santé Arménie Medical Academy shared a post on LinkedIn: "We are thrilled to announce the official…
May 7, 2025, 09:26 | Science
Aaron Hansen: New Chemotherapy Database to Monitor Ovarian Cancer Treatment in New Zealand
Aaron Hansen, Acting Medical Director Cancer Services at Princess Alexandra Hospital, shared an article on LinkedIn:…
May 5, 2025, 16:04 | Blog
Immunotherapy with Chemoradiotherapy Reduces Surgical Need in Rectal Cancer - ESTRO
European Society for Radiotherapy and Oncology (ESTRO) shared a post on LinkedIn: "ESTRO25 Press release.…
May 4, 2025, 01:51 | Blog
AACR25 Clinical Trials plenary highlights advances in expanding Immunotherapy access
AACR shared a post on X: "Clinical Trials Plenary Session: Advances in Immunotherapy — Researchers presented…
May 3, 2025, 21:10 | Blog
Douglas Flora Highlights MSKCC Immunotherapy Trial for MMRd Tumors at AACR 2025
Douglas Flora, President-Elect at Association of Cancer Care Centers, shared on LinkedIn: "Significant Findings Presented…
May 2, 2025, 18:25 | Science
LOXHD1 Identified as Immunotherapy Target in Ewing Sarcoma - Parker Institute for Cancer Immunotherapy
Parker Institute for Cancer Immunotherapy shared a post on X: "Few cancers rob young lives…
May 2, 2025, 16:17 | Blog
Myriam Chalabi Discusses Neoadjuvant Immunotherapy and NEOASIS Study Findings at AACR25 - Agenus
Agenus shared a post on LinkedIn: "Yesterday at AACR25, Dr. Myriam Chalabi participated in the…
May 2, 2025, 10:51 | Blog
Beau Bosko Toskich: Combining Local Therapy and Immunotherapy in Intermediate Stage HCC
Beau Bosko Toskich, Professor of Radiology and Director of Interventional Oncology at Mayo Clinic Florida,…
May 2, 2025, 10:21 | Blog
AACR 2025 in Focus: Top Highlights from the Annual Meeting
Every year, the AACR Annual Meeting brings together the global cancer research community—and every year,…
May 2, 2025, 05:48 | Insight
Analysis Highlights Multi-Organ Adverse Events from Cancer Immunotherapies - FDA
FDA shared a post on LinkedIn: "A descriptive analysis by FDA clinical reviewers using clinical…
May 1, 2025, 06:32 | Insight
Amazing work from the BITOX to treat patients with immunotherapy - Belgian Society of Medical Oncology
Belgian Society of Medical Oncology shared a post by BITOX, adding: "Amazing work from the…
Apr 30, 2025, 08:50 | Science
Updates from AACR25 by Amol Akhade
Amol Akhade, Consultant Medical Oncologist and Hemato-oncologist at Suyog Cancer Clinics, shared an updates from…
Apr 28, 2025, 13:16 | Insight
Amol Akhade: Insights on KEYNOTE-689 immunotherapy breakthrough in non-metastatic HNSCC at AACR 2025
Amol Akhade, Consultant Medical Oncologist and Hemato-oncologist at Suyog Cancer Clinics, shared a post on…
Apr 28, 2025, 12:57 | Insight
ctDNA after surgery for MMRd tumors can prevent cancer recurrence - Yelena Janjigian at AACR25
Memorial Sloan Kettering Cancer Center shared a post on LinkedIn: "In a plenary session at…
Apr 28, 2025, 08:40 | Blog
Binaytara Foundation Highlights Global Oncology Innovations at SCHD25
Binaytara – shared on X: “The Global Oncology session at SCHD25 packed multiple innovations into…
Apr 26, 2025, 12:32 | Blog
Fady Geara: Phase II Study of Upfront Immunotherapy with Radiation and TNT in MS-S Rectal Cancer
Fady Geara, Professor and Chairman at Cleveland Clinic Abu Dhabi, posted on LinkedIn: "Our multi…
Apr 26, 2025, 12:23 | Blog
Jarushka Naidoo: Honored to Serve as Track Chair for Developmental Therapeutics/Immunotherapy at ASCO
Jarushka Naidoo, Full Professor and Consultant Medical Oncologist at Royal College of Surgeons in Irelan,…
Apr 25, 2025, 13:35 | Blog
Jill Feldman: We must talk about pneumonitis in lung cancer
Jill Feldman, Co-Founder of EGFR Resisters, shared a post on X: "We must talk about pneumonitis…
Apr 25, 2025, 11:15 | Blog
Amol Akhade: Data to look forward at AACR2025
Amol Akhade, Senior consultant medical oncologist and hemato-oncologist at Suyog Cancer Clinics and Reliance Hospitals, shared…
Apr 25, 2025, 11:05 | Blog
MD Anderson researchers are set to present breakthrough findings at the 2025 AACR Annual Meeting
MD Anderson Cancer Center shared a post on LinkedIn: "MD Anderson researchers are set to present…
Apr 25, 2025, 09:57 | Blog
What to Expect at the AACR Annual Meeting 2025: Key Highlights and Must-Attend Sessions​
The AACR Annual Meeting 2025, taking place from April 25–30 at McCormick Place Convention Center…
Apr 25, 2025, 05:55 | Drugs
Durvalumab (Imfinzi): What patients need to know?
Durvalumab is a cancer immunotherapy designed to help the immune system recognize and attack cancer…
Apr 25, 2025, 02:46 | Oncolibrary
FDA Approves Penpulimab for Recurrent or Metastatic Non-Keratinizing Nasopharyngeal Carcinoma
On April 23, 2025, the U.S. Food and Drug Administration (FDA) granted accelerated approval to…
Apr 24, 2025, 12:10 | Science
Joshua Brody: Quick summary on using CRISPR to edit T-cells
Joshua Brody, Director of Lymphoma Immunotherapy Program and Associate Professor of Division of Hematology and…
Apr 24, 2025, 11:06 | Blog
New dosing options for PD-1 inhibitor in first and second-line esophageal squamous cell carcinoma - BeOne Medicines
BeOne Medicines shared a post on LinkedIn: "The FDA has approved new dosing options for our…
Apr 23, 2025, 10:12 | Blog
Matthew Kurian: From ASCENT-04 may reshape frontline therapy for mTNBC
Matthew Kurian, Assistant professor of medicine at the University of Kentucky College of Medicine, shared a…
Apr 22, 2025, 15:38 | Blog
Nicholas DeVito Highlights Enrollment for BBOpCo Immunotherapy Trial
Nicholas DeVito, Assistant Professor at Duke Cancer Institute, shared the following insightful post on LinkedIn:…
Apr 22, 2025, 14:05 | Blog
Nicholas DeVito: Duke's first-line immunotherapy trial for advanced/metastatic CRC is still enrolling
Nicholas DeVito, Assistant Professor of Medicine at the Division of Medical Oncology at Duke University, shared…
Apr 22, 2025, 11:06 | Blog
How immune cell baselines may predict CD22 therapy outcomes in Pediatric Cancer - NCI Center for Cancer Research
NCI Center for Cancer Research shared a post on LinkedIn: "CD22 CAR T-cell immunotherapy is an…
Apr 22, 2025, 06:40 | Blog
Elvina Almuradova: Trodelvy plus Keytruda Boosts PFS in PD-L1+ mTNBC Patients
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared a…
Apr 22, 2025, 05:25 | Blog
E. Shyam P. Reddy: Older adults respond well to immunotherapy despite age-related immune system differences
E. Shyam P. Reddy, Professor and Director of Cancer Biology Program at Morehouse School of…
Apr 20, 2025, 11:14 | Blog
Join Aurélien Marabelle on SITC's A Focus on Intratumoral Therapies, Vaccines and Cytokines live webinar
Aurélien Marabelle, Medical Oncologist at Gustave Roussy and Professor of Clinical Immunology at Paris-Saclay University,…
Apr 20, 2025, 11:06 | Drugs
Loqtorzi (Toripalimab): What patients need to know?
Toripalimab (Loqtorzi) is a PD-1 inhibitor, a type of immune checkpoint inhibitor that works by…
Apr 20, 2025, 02:27 | Blog
Let’s Talk About Liver Cancer – On World Liver Day
Today is World Liver Day, a time to show some love to one of the…
Apr 19, 2025, 18:05 | Blog
Prasad Raj Dandekar: A detailed conversation about immunotherapy with Sewanti Limaye
Prasad Raj Dandekar, Head of Radiation Oncology at Sir H. N. Reliance Foundation Hospital and…
Apr 19, 2025, 03:00 | Cancer Types
Small Cell Lung Cancer: Symptoms, Causes, Types, Diagnosis and Treatment
Small cell lung cancer (SCLC) is a highly aggressive subtype of lung cancer that originates…
Apr 19, 2025, 01:00 | Blog
Norman Ng: Joanne Chiu discusses the remarkable advancements in cancer treatment and the potential for long-term survival
Norman Ng, Director of Patient Advocacy and Public Affairs at Healthcare Thinkers, shared a post…
Apr 18, 2025, 18:41 | Blog
Patrick Hwu: The ImmunoVerse podcast is almost here
Patrick Hwu, President and CEO of Moffitt Cancer Center, shared a post on LinkedIn: "Exciting…
Apr 18, 2025, 15:43 | Blog
ESGO - Tumour Board Webinar: Mechanisms of Drug Resistance: PARP, ADC, Immunotherapy
European Society of Gynaecological Oncology (ESGO) posted on LinkedIn: "Next week, Jonathan Ledermann and Damiano…
Apr 18, 2025, 08:19 | Blog
This is a great explanation of how immunotherapy is different to traditional cancer therapies - FACS-ASPIRE
Foundation for Autoimmune Cancer Support (FACS-ASPIRE) shared a post by Agenus: "This is a great…
Apr 18, 2025, 01:05 | Opinion
Zunairah Shah: So happy to be selected for the SITC 2025 WIN Leadership Institute
Zunairah Shah, Hem/Onc fellow at Roswell Park Comprehensive Cancer Center, shared a post on X:…
Apr 17, 2025, 02:14 | Career
Caryn Lerman: John P. Murad was awarded the Tower Cancer Research Foundation Career Development Award
Caryn Lerman, Director of Norris Comprehensive Cancer Center at Keck Medicine of USC, shared a…
Apr 16, 2025, 13:06 | Blog
He’d tried everything. But the cancer kept growing - Cancer Research Institute
Cancer Research Institute (CRI) shared a post on LinkedIn: "He’d tried everything. But the cancer…
Apr 16, 2025, 09:40 | Immune Oncology
What Are the Signs That Immunotherapy Is Working?
Immunotherapy has revolutionized cancer treatment by activating the body’s immune system to recognize and destroy…
Apr 16, 2025, 07:43 | Blog
Transforming melanoma treatment in Manchester - Manchester Cancer Research Centre
Manchester Cancer Research Centre shared a post on LinkedIn: "Transforming melanoma treatment in Manchester. Melanoma…
Apr 15, 2025, 12:34 | Blog
Chandler Park: Great privilege to advocate for cancer patients at the 2025 ASCO Advocacy Summit
Chandler Park, Advisory Dean and Clinical Professor at University of Louisville School of Medicine, shared a…
Apr 15, 2025, 09:48 | Blog
Marcin Kortylewski: Multimodal Glioma Immunotherapy Targeting STAT3 and PD-1
Marcin Kortylewski, Professor at City of Hope, posted on LinkedIn: "Just published! Our latest study…
Apr 15, 2025, 07:09 | Blog
Roberto Ferrara: Neoadjuvant versus perioperative chemo-immunotherapy according to pathological response in resectable NSCLC
Roberto Ferrara, Medical Oncologist,Researcher in Thoracic Oncology and Molecular Immunology at Vita-Salute San Raffaele University,…
Apr 15, 2025, 02:05 | Blog
Daniel Flora: About Teddi Mellencamp’s stage IV melanoma and her treatment with immunotherapy
Daniel Flora, Medical Director of Oncology Research at St. Elizabeth Healthcare, shared a post on…
Apr 14, 2025, 15:11 | Science
A clinical trial for patients with high-grade neuroendocrine tumors is now open for enrollment at Sylvester Comprehensive Cancer Center
A clinical trial for patients with high-grade neuroendocrine tumors is now open for enrollment at…
Apr 14, 2025, 09:32 | Blog
Yan Leyfman: Pluri Secures U.S. Patent for Immune Cell Expansion Technology
Yan Leyfman, Co-founder and executive director of MedNews Week, posted on LinkedIn: "Pluri (Nasdaq: PLUR)…
Apr 13, 2025, 16:08 | Insight
iwCAR-T 2025 Highlights – Unleashing the Next Frontier in Immunotherapy
The 7th International Workshop on CAR-T and Bispecific Antibodies (iwCAR-T 2025) convened in Miami, Florida,…
Apr 13, 2025, 14:44 | Blog
First-in-Human PIIO-1 Trial for Recurrent Glioblastoma Receives IND Approval - Pelotonia Institute for Immuno-Oncology
Pelotonia Institute for Immuno-Oncology shared a post on X: "We’re celebrating IND approval for the first…
Apr 13, 2025, 09:37 | Blog
Congratulations to Mark Ball and Stephanie Goff for their recent appointments within CCR - NCI Center for Cancer Research
NCI Center for Cancer Research shared a post on LinkedIn: "Congratulations to Mark Ball and…
Apr 13, 2025, 05:10 | Blog
Agenus - Harnessing the Immune System for Curative Cancer Therapies
Agenus posted on LinkedIn: "Not all cancer treatments work the same way. Immunotherapy harnesses the…
Apr 13, 2025, 04:11 | Blog
Cathy Eng: Thank you to Brazilian GI Tumors Group for the invitation to speak at their annual meeting
Cathy Eng, VICC Associate Director, Strategic Relations and Research Partnerships at Vanderbilt-Ingram Cancer, shared a…
All: 793 Posts: 1 - 100
Special Coverage